Study: Akowuah 2024, Journal of Complementary and Integrative Medicine
Vernonia amygdalina aqueous leaf extract modulates metformin pharmacokinetics, inhibits CYP3A4 and CYP2C9 enzymes in streptozotocin-induced diabetic rats
Citation
Akowuah GA, Sabbagh BA, Palanirajan VK, Chew YL et al (2024). Journal of Complementary and Integrative Medicine. PubMed id 39710889.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Bush teas and herbal remedies (cerasee, bitter leaf) with medicines Tier B thin
C Diabetic rats (4 groups of 6) and enzyme assays (n=24 rats)
Single-dose experiment of bitter leaf aqueous leaf extract with metformin.
Given with metformin, the extract changed metformin's pharmacokinetics (higher peak level, higher total exposure and longer half-life) and inhibited the liver enzymes CYP3A4 and CYP2C9 in the assay. The authors say this suggests potential herb-drug interactions.
As recorded in this card: Akowuah GA, Sabbagh BA, Palanirajan VK, Chew YL et al (2024), Journal of Complementary and Integrative Medicine, [primary]
Note: Rats only, one dose; a signal worth a pharmacist check, not a measured human risk.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.